Over-the-Counter Antihistamines & Heat Stress

PHASE4RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Heat IllnessAllergic RhinitisHeat InjurySudomotor Sympathetic Dysfunction
Interventions
DRUG

50 mg Diphenhydramine

Participants ingest 50mg of diphenhydramine orally \~2 hours prior to a passive heating protocol. Participants then don a water-perfusion heat suited and lay supine on assessment table while 49℃ is circulated throughout the garment. Heating persists until participants reach a 1.5℃ increase in core temperature from baseline.

DRUG

10 mg Loratadine

Participants ingest 10 mg of loratadine orally \~2 hours prior to a passive heating protocol. Participants then don a water-perfusion heat suited and lay supine on assessment table while 49℃ is circulated throughout the garment. Heating persists until participants reach a 1.5℃ increase in core temperature from baseline.

DRUG

5 mg Desloratadine

Participants ingest 5 mg of desloratadine orally \~2 hours prior to a passive heating protocol. Participants then don a water-perfusion heat suited and lay supine on assessment table while 49℃ is circulated throughout the garment. Heating persists until participants reach a 1.5℃ increase in core temperature from baseline.

OTHER

Placebo (Sugar Pill)

Participants ingest placebo pill orally \~2 hours prior to a passive heating protocol. Participants then don a water-perfusion heat suited and lay supine on assessment table while 49℃ is circulated throughout the garment. Heating persists until participants reach a 1.5℃ increase in core temperature from baseline.

Trial Locations (1)

P7B5E1

RECRUITING

Lakehead University C.J Sanders Fieldhouse, Thunder Bay

All Listed Sponsors
lead

Lakehead University

OTHER